Subramanian Ammashi

Subramanian Ammashi

Auto-generated profile, based on publicly available information

Subramanian Ammashi

PG and Research Department of Biochemistry, Rajah Serfoji Government College (Autonomous)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
KRKarthika Rajamanickam
Karthika Rajamanickam
TRThirumalaisamy Rathinavel
Thirumalaisamy Rathinavel
VPVelu Periyannan
Velu Periyannan
SASubramanian Ammashi
Subramanian Ammashi
SMShanmugam Marimuthu
Shanmugam Marimuthu
MIMuhammad Nasir Iqbal
Muhammad Nasir Iqbal
Human corona viral infection leads to acute breathing disease and death if not diagnosed and treated properly in time. The disease can be treated with the help of simple natural compounds, which we use in day-to-day life. These natural compounds act against several diseases but their drug targeting mechanism needs to be improved for more efficient and promising applications. In the present study five compounds (gingerol, thymol, thymohydroquinone, cyclocurcumin, hydrazinocurcumin) from three Indian medicinal plants (ginger, black cumin, turmeric) and its hyaluronic acid (HA) conjugates were docked against initially deposited spike structural proteins (PDB ID 6WPT) and its mutant variant D-614G (PDB ID 6XS6). Docking study result reveals that all the HA conjugates showed the most effective inhibitor of S-protein of initially deposited and D-614G variant forms of SARS-CoV-2. The compounds like Gingerol, Thymol, Thymohydroquinone, Cyclocurcumin, Hydrazinocurcumin, Hydroxychloroquinone, and hyaluronic acid conjugates inhibit the viral protein of both wild-type and mutated S-protein of SARS-CoV-2. The molecular docking studies of phytocompounds with initial deposited and variant spike protein targets show superior binding affinity than with the commercial repurposed viral entry inhibitor hydroxychloroquine. Further, the docking result was modeled using MD simulation study shows excellent simulation trajectories between spike proteins and HA conjugates spices constituents than its free form. DFT analysis was carried out to affirm the reason behind the highest binding affinity of HA conjugates over its free form towards SARS-CoV-2 spike protein targets. Further HA conjugates synthesis and its evaluation against SARS-CoV-2 in vitro studies are needed to prove our novel idea for an anti-viral drug. Graphical Abstract Communicated by Ramaswamy H. Sarma

3 July 2022 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
VSVasuki Selvaraj
Vasuki Selvaraj
TRThirumalaisamy Rathinavel
Thirumalaisamy Rathinavel
SASubramanian Ammashi
Subramanian Ammashi
MIMuhammad Nasir Iqbal
Muhammad Nasir Iqbal